Europe Looks to Cells for a Healthier Future
Our body’s cells are constantly changing. The question is: which of these changes are healthy developments and which lead to serious diseases? This is what LifeTime, a new transnational and interdisciplinary initiative of leading European researchers, aims to discover. The Max Delbrück Center in Berlin and the Institut Curie in Paris coordinates the consortium in partnership with the Helmholtz Association and the CNRS. Together, they have recently cleared an important hurdle: LifeTime will be given one year and one million euros to develop a plan to integrate its vision for a healthier future into the thriving European landscape of research and innovation.
“This is a great opportunity,” says Professor Nikolaus Rajewsky, who heads the MDC’s Berlin Institute for Medical Systems Biology (BIMSB), a hot spot for single-cell analysis. Rajewsky is one of the two main coordinators of the research consortium. “All of LifeTime’s members are among the best in their respective fields. They’re doing visionary work. We will use this year to intensify our collaboration, share our vision and extend our network within Europe and beyond.” A launch conference will be held in Berlin on May 6th and 7th, 2019, where the consortium’s members will introduce LifeTime and share information on how LifeTime plans to strengthen life sciences and healthcare in Europe.
About LifeTime: LifeTime is a common vision of more than 120 scientists from 53 research institutions across 18 countries. The initiative is jointly coordinated by Nikolaus Rajewsky from the Max Delbrück Center for Molecular Medicine (MDC) and Geneviève Almouzni from the Institut Curie.
Prof. Dr. Nikolaus Rajewsky
Leiter Berlin Institute of Medical Systems Biology (BIMSB) am Max-Delbrück-Centrum für Molekulare Medizin (MDC)
More information can be found here.